This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | PATHglobalhealth |
| Website | http://www.path.org/ |
| Twitter username | pathtweets |
| Wikipedia page | https://en.wikipedia.org/wiki/PATH_%28global_health_organization%29 |
| Instagram username | pathglobalhealth |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 363 | 625,000 | 4,086,818 | -27,464,783 | 0 | 50,387 | 131,504 | 311,212 | 625,000 | 1,050,000 | 1,800,000 | 3,854,562 | 9,000,000 | 168,731,146 |
| Global health | 292 | 521,704 | 4,672,566 | -27,464,783 | 0 | 10,000 | 100,000 | 256,509 | 521,704 | 1,139,525 | 2,356,234 | 4,340,498 | 10,000,000 | 168,731,146 |
| Family planning | 21 | 1,500,000 | 2,687,753 | -620,992 | 0 | 600,000 | 620,992 | 1,370,050 | 1,500,000 | 1,562,727 | 2,999,663 | 4,000,000 | 7,341,131 | 10,106,727 |
| Nutrition | 8 | 195,817 | 1,489,236 | -153,179 | 0 | 0 | 187,177 | 195,817 | 195,817 | 832,305 | 998,543 | 3,854,562 | 5,999,480 | 5,999,480 |
| Population | 16 | 900,000 | 853,125 | 25,000 | 100,000 | 275,000 | 625,000 | 900,000 | 900,000 | 1,100,000 | 1,250,000 | 1,250,000 | 1,250,000 | 1,500,000 |
| FIXME | 14 | 250,000 | 331,880 | 40,000 | 100,000 | 100,000 | 150,000 | 250,000 | 250,000 | 300,000 | 350,000 | 400,000 | 400,000 | 1,500,000 |
| Global development | 1 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 |
| Multisector aid | 1 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 | 345,000 |
| Past Programs | 6 | 750,000 | 841,667 | 500,000 | 500,000 | 600,000 | 600,000 | 750,000 | 750,000 | 800,000 | 900,000 | 900,000 | 1,500,000 | 1,500,000 |
| Agriculture | 3 | 671,360 | 725,176 | 652,365 | 652,365 | 652,365 | 652,365 | 671,360 | 671,360 | 671,360 | 851,802 | 851,802 | 851,802 | 851,802 |
| Water | 1 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 | 24,602,129 |
| Donor | Total | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999 | 1998 | 1996 | 1995 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 1,460,168,631.46 | 0.00 | 22,885,013.00 | 241,229,363.15 | 159,551,591.54 | 69,105,972.67 | 248,626,802.30 | 105,021,002.71 | 28,465,141.00 | 66,162,283.02 | 31,860,607.00 | 101,374,490.07 | 186,005,660.00 | 95,191,451.00 | 104,689,254.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hewlett Foundation (filter this donee) | 13,650,000.00 | 850,000.00 | 0.00 | 0.00 | 2,500,000.00 | 0.00 | 0.00 | 2,500,000.00 | 275,000.00 | 0.00 | 1,250,000.00 | 100,000.00 | 25,000.00 | 1,500,000.00 | 200,000.00 | 925,000.00 | 625,000.00 | 1,800,000.00 | 0.00 | 1,100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Andrew W. Mellon Foundation (filter this donee) | 5,050,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,100,000.00 | 500,000.00 | 900,000.00 | 800,000.00 | 750,000.00 | 0.00 |
| MacArthur Foundation (filter this donee) | 3,455,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250,000.00 | 0.00 | 0.00 | 300,000.00 | 115,000.00 | 0.00 | 400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100,000.00 | 0.00 | 250,000.00 | 40,000.00 | 0.00 | 350,000.00 | 1,650,000.00 |
| Ford Foundation (filter this donee) | 1,191,315.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 494,542.00 | 0.00 | 696,773.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 1,483,514,946.46 | 850,000.00 | 22,885,013.00 | 241,229,363.15 | 162,051,591.54 | 69,355,972.67 | 248,626,802.30 | 107,521,002.71 | 29,040,141.00 | 66,277,283.02 | 33,110,607.00 | 102,369,032.07 | 186,030,660.00 | 97,388,224.00 | 104,889,254.00 | 925,000.00 | 625,000.00 | 1,800,000.00 | 100,000.00 | 3,200,000.00 | 750,000.00 | 940,000.00 | 800,000.00 | 1,100,000.00 | 1,650,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 363) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Hewlett Foundation | 850,000.00 | 166 | Population | https://hewlett.org/grants/path-for-paths-sexual-and-reproductive-health-program/ | -- | For PATH's Sexual And Reproductive Health Program. | |
| Bill and Melinda Gates Foundation | 8,052,939.00 | 41 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -88,187.00 | 337 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to increase women’s access to safe, effective and discreet contraception by facilitating introduction and delivery of subcutaneous contraceptive (depo-subQ in uniject (Sayana Press)) through community, clinic and social marketing channels and undertaking ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 88,187.00 | 272 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to plan, coordinate, and track implementation, and share information on progress and results for the introduction, scale-up, and integration of the DMPA SubQ injectable contraceptive into national family planning programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|South of Sahara; affected countries: India. | |
| Bill and Melinda Gates Foundation | 1,529,102.70 | 117 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to advocate for evidence-based policy change and implementation and to mobilize domestic and global resources that will advance women's and children's health in the Democratic Republic of Congo, Kenya, Uganda and globally, and advance global health resear; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Congo (the)|Kenya|South africa|Uganda. | |
| Bill and Melinda Gates Foundation | 169,900.30 | 245 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advocate for evidence-based policy change and implementation and to mobilize domestic and global resources that will advance women's and children's health in the Democratic Republic of Congo, Kenya, Uganda and globally, and advance global health resear; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Congo (the)|Kenya|South africa|Uganda. | |
| Bill and Melinda Gates Foundation | 2,475,013.00 | 95 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify and develop a Group B streptococcus glyco-conjugate vaccine candidate by an African vaccine manufacturer.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 137,343.00 | 252 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to collect, synthesize, frame, and share evidence-informed learnings and best practices around the improvement and use of data to improve immunization outcomes.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -117,325.00 | 339 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advance the availability and uptake of programmatically suitable tools to improve the efficiency of data-driven vaccination systems in collaboration with country and global stakeholders; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 117,325.00 | 259 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to improve the availability of optimal and functional cold chain equipment and interventions and to advance controlled temperature chain use of vaccines to ensure that effective vaccines are available to all who need them; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 99,992.00 | 271 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to generate data to inform country- and global-level decision-making related to fractional dose inactivated poliovirus vaccine (fIPV) introduction; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,233,440.00 | 103 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support translation of evidence around new approaches (as well as existing and new tools) for elimination into actionable and fundable strategies, plans, and measurable impact in Ethiopia and Senegal; Aid type: Project-type interventions. Affected countries: Ethiopia|Senegal. | |
| Bill and Melinda Gates Foundation | -73,791.00 | 334 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to focus on innovation introduction and reducing policy barriers to service delivery implementation; Aid type: Project-type interventions. Affected regions: Europe; affected countries: Kenya|Zambia|United states of america (the)|United kingdom of great britain and northern ireland (the)|Congo (the democratic republic of the)|South africa. | |
| Bill and Melinda Gates Foundation | 66,411.90 | 285 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to advocate for evidence-based policy change and implementation and to mobilize domestic and global resources that will advance women's and children's health in the Democratic Republic of Congo, Kenya, Uganda and globally, and advance global health resear; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Congo (the)|Kenya|South africa|Uganda. | |
| Bill and Melinda Gates Foundation | 7,379.10 | 301 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advocate for evidence-based policy change and implementation and to mobilize domestic and global resources that will advance women's and children's health in the Democratic Republic of Congo, Kenya, Uganda and globally, and advance global health resear; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Congo (the)|Kenya|South africa|Uganda. | |
| Bill and Melinda Gates Foundation | 3,571,609.00 | 77 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To transfer technology and to develop the manufacturing processes for the P2-VP8 trivalent non-replicating rotavirus vaccine at SK Chemicals, Seoul, South Korea; a potential vaccine against severe rotavirus disease in infants; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 438,552.00 | 202 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to collect, synthesize, frame, and share evidence-informed learnings and best practices around the improvement and use of data to improve immunization outcomes.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,455,013.00 | 55 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development and availability of point-of-care diagnostic tests for G6PD deficiency that ensure that this class of drugs can be safely distributed in low-resource settings where P. vivax is most endemic and has the largest economic and he; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 86,250.00 | 274 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to equip policymakers and practitioners with the knowledge, tools, and skills they need to build strong health care systems for universal health coverage, focusing on information systems and use, provider payment mechanisms, and people-centered integrated; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -620,992.00 | 350 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to develop the capacity of the Reproductive Health Supply coalition. RHSC - Reproductive Health Supplies Coalition Secretariat. Investment start date: 2/20/2013 to end date: 6/30/2018. Grantee name: PATH; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 620,992.00 | 183 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to mobilize the collective strengths of our member organizations to increase access to a full range of affordable, quality reproductive health supplies in low and middle income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -551,573.00 | 349 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to promote early TB diagnosis and accountable treatment for patients seeking care from private health care sector outlets in Mumbai; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | -812,568.00 | 353 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to address the gaps in Neglected Tropical Diseases (NTD) diagnostics by catalyzing the diagnostics industry to advance the development and commercialization of new diagnostic tools needed by the NTD community. More sensitive and specific tools are require; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,780,821.00 | 64 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,755,970.60 | 20 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to advocate for evidence-based policy change and implementation and to mobilize domestic and global resources that will advance women's and children's health in the Democratic Republic of Congo, Kenya, Uganda and globally, and advance global health resear; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Congo (the)|Kenya|South africa|Uganda. | |
| Bill and Melinda Gates Foundation | 1,750,663.40 | 111 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advocate for evidence-based policy change and implementation and to mobilize domestic and global resources that will advance women's and children's health in the Democratic Republic of Congo, Kenya, Uganda and globally, and advance global health resear; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Congo (the)|Kenya|South africa|Uganda. | |
| Bill and Melinda Gates Foundation | 259,109.00 | 228 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to celebrate the success of bringing two new rotavirus vaccines through WHO pre-qualification; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. Grantee Site Visit 2017. Investment start date: 12/4/2017 to end date: 1/1/2018. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | -270,000.00 | 343 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to focus on innovation introduction and reducing policy barriers to service delivery implementation; Aid type: Project-type interventions. Affected regions: Europe; affected countries: Kenya|Zambia|United states of america (the)|United kingdom of great britain and northern ireland (the)|Congo (the democratic republic of the)|South africa. | |
| Bill and Melinda Gates Foundation | 325,420.00 | 216 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support preparation activities relating to an efficacy study of the non-replicating rotavirus vaccine (NRRV).; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 27,863,472.00 | 13 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop safer, novel, monovalent oral polio vaccines against poliovirus types 1 and 3 for outbreak use; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 342,013.87 | 215 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 486,019.71 | 197 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 486,019.71 | 197 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 486,019.71 | 197 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,984,467.00 | 59 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to increase the evidence base regarding the efficacy of vaccination of women during pregnancy against pertussis, thereby supporting efforts to make available a potentially high-impact intervention to reduce pertussis in mothers and newborns; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: Zambia|Pakistan. | |
| Bill and Melinda Gates Foundation | 2,389,059.00 | 98 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to generate immunogenicity and safety data on the BBIL rotavirus vaccine, ROTAVAC and ROTAVAC 5C, in one African country, which will support WHO SAGE policy recommendations and country-level decision-making on potential use of these vaccines; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | -1,440,000.00 | 355 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the regional elimination program in South Asia by getting a safe and effective treatment for visceral leishmaniasis, paromomycin intramuscular injection, registered and adopted by the governments of Bangladesh and Nepal; Aid type: Project-type interventions. Affected countries: Bangladesh|Nepal. | |
| Bill and Melinda Gates Foundation | 244,628.00 | 235 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to fund oversight of outstanding agreements related to the licensing and commercialization of the Ov16 and Wb123 rapid diagnostic tests, affording control and elimination programs in endemic areas access to the tests; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 2,016,434.00 | 105 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to test whether inactivated polio vaccine delivered intramuscularly with double mutant heat-labile toxin of E. coli induces gut mucosal immune responses and decreases shedding of poliovirus, reducing transmission in the population; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,335,358.00 | 130 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to collect, synthesize, frame, and share evidence-informed learnings and best practices around the improvement and use of data to improve immunization outcomes.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 851,802.00 | 165 | Agriculture/agricultural development | https://iatiregistry.org/publisher/bmgf | -- | to improve livestock diagnostics tools for use by smallholder farmers in low and middle-income countries by undertaking a landscape analysis of livestock diagnostics and recommending a broader investment strategy aimed at furthering the field of livestock; Aid type: Project-type interventions. Affected regions: Asia|Africa. | |
| Bill and Melinda Gates Foundation | 3,642,333.00 | 76 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support a partner in establishing a coordinating body to support evidence generation, impact modeling, policy alignment and preparation for a sustained single-dose Human papillomavirus (HPV) strategy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 86,030.00 | 275 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support identification of back-end nucleic acid amplification and detection systems with the potential to integrate into a low-cost pathogen detection system; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 6,067,882.00 | 51 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to improve the availability of optimal and functional cold chain equipment and interventions and to advance controlled temperature chain use of vaccines to ensure that effective vaccines are available to all who need them; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 350,000.00 | 210 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide quantified sample panels to diagnostic test developers being funded by the Bill & Melinda Gates Foundation and perform unbiased evaluations and appraisals of diagnostic technologies upon request; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,000,000.00 | 56 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support a sustainable environment for the development and adoption of reusable Global Goods in order to improve the quality of health information at national, regional, and global levels; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 350,000.00 | 210 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to improve the detection of poliovirus in environmental samples using the bag-mediated filtration system; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,468,248.00 | 96 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support the placement a small scale demonstration of a fully functioning Global Visibility & Analytics Network (VAN) for reproductive health needs.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 7,250,000.00 | 45 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to plan, coordinate, and track implementation, and share information on progress and results for the introduction, scale-up, and integration of the DMPA SubQ injectable contraceptive into national family planning programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|South of Sahara; affected countries: India. | |
| Bill and Melinda Gates Foundation | 448,052.00 | 201 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to facilitate availability of novel vaccine products and presentations to increase coverage and equity and improve global and government decision making around new product or presentation choices; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 120,283,674.00 | 3 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to transform the business and operating model for PATH's vaccine development efforts in order to speed the efficient and effective progression of a vaccine pipeline with industry-standard quality; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,000,000.00 | 21 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to improve the performance of Tanzania’s Primary Health Care system through better use of data.; Aid type: Project-type interventions. Affected countries: Tanzania, united republic of. | |
| Bill and Melinda Gates Foundation | -77,571.71 | 335 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish a home for cross-Product Development Partnership (PDP) regulatory support, and provide evidence that the model both strengthens regulatory capacity for PDP products and is more efficient than establishing resources at individual PDPs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 110,940.62 | 262 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 157,652.46 | 246 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 157,652.46 | 246 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 157,652.46 | 246 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 61,592.00 | 289 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify the “best in class” nucleic acid extraction technologies that may better enable diagnosis of disease at the point-of-care; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,662,279.00 | 112 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To develop monoclonal antibodies to all pneumococcal serotypes and have a repository so that these can be used in future vaccine development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 345,000.00 | 213 | Multisector aid | https://iatiregistry.org/publisher/bmgf | -- | to support an open source tool to support mobile data management to enhance long term impact in global development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -1,496,723.14 | 356 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to address the gaps in Neglected Tropical Diseases (NTD) diagnostics by catalyzing the diagnostics industry to advance the development and commercialization of new diagnostic tools needed by the NTD community. More sensitive and specific tools are require; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 581,364.00 | 189 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to strengthen the Directorate of Vector Borne Diseases in Uttar Pradesh to control and eliminate the key Neglected Tropical Diseases; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 11,382.00 | 299 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify the “best in class” nucleic acid extraction technologies that may better enable diagnosis of disease at the point-of-care; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,000.00 | 302 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. 2017 PATH 40th Anniversary Dinner. Investment start date: 4/14/2017 to end date: 5/12/2017. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 4,000,000.00 | 69 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to mobilize the collective strengths of our member organizations to increase access to a full range of affordable, quality reproductive health supplies in low and middle income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,972,684.00 | 61 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to improve the detection of poliovirus in environmental samples using the bag-mediated filtration system; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 784,696.00 | 171 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to generate data to inform country- and global-level decision-making related to fractional dose inactivated poliovirus vaccine (fIPV) introduction; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 80,383.00 | 277 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify the “best in class” nucleic acid extraction technologies that may better enable diagnosis of disease at the point-of-care; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,925,329.00 | 53 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To transfer technology and to develop the manufacturing processes for the P2-VP8 trivalent non-replicating rotavirus vaccine at SK Chemicals, Seoul, South Korea; a potential vaccine against severe rotavirus disease in infants; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 196,055.00 | 240 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to contribute to the elimination of meningococcal meningitis epidemics as a public health problem in sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 8,455,061.00 | 39 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 652,365.00 | 180 | Agriculture/agricultural development | https://iatiregistry.org/publisher/bmgf | -- | to improve livestock diagnostics tools for use by smallholder farmers in low and middle-income countries by undertaking a landscape analysis of livestock diagnostics and recommending a broader investment strategy aimed at furthering the field of livestock; Aid type: Project-type interventions. Affected regions: Asia|Africa. | |
| Bill and Melinda Gates Foundation | 5,500,000.00 | 54 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support PATH’s next phase of infrastructure that will support the discovery, development and delivery of global health interventions to those who need them most; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,500,000.00 | 92 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,019,533.00 | 68 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to equip policymakers and practitioners with the knowledge, tools, and skills they need to build strong health care systems for universal health coverage, focusing on information systems and use, provider payment mechanisms, and people-centered integrated; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 242,946.00 | 236 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to enable testing of double mutant heat-labile toxin of E. coli (dmLT) Inactivated Polio Vaccine in inducing immune responses, which could have important implications in global polio preparedness and eradication; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,638,159.00 | 89 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop safer, novel, monovalent oral polio vaccines against poliovirus types 1 and 3 for outbreak use; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 46,001.47 | 293 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 65,370.51 | 286 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 65,370.51 | 286 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 65,370.51 | 286 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,250,000.00 | 132 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to develop the capacity of the Reproductive Health Supply coalition. RHSC - Reproductive Health Supplies Coalition Secretariat. Investment start date: 2/20/2013 to end date: 6/30/2018. Grantee name: PATH; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,500,000.00 | 78 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to generate evidence and guidance that decision-makers in Uganda, other FP2020 countries and at the global level can use to design, introduce and advance scalable self-injection programs; Aid type: Project-type interventions. Affected countries: Uganda. | |
| Bill and Melinda Gates Foundation | 2,899,986.00 | 86 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to strengthen the World Health Organization Performance, Quality and Safety team’s ability to accelerate prequalification of improved cold chain equipment and increase quality assurance oversight of installed cold chain equipment; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 521,704.00 | 190 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support National Vector Borne Disease Control Program for strengthening the process for control and elimination of vector-borne diseases; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 342,691.00 | 214 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate a reduction in global cervical cancer incidence and mortality by helping countries with a high burden of cervical cancer introduce new screening technologies and cervical cancer prevention best practices; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 832,305.00 | 167 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to develop and validate innovative, accurate, rapid, and cost-effective surveillance tools that will enable country-based surveillance of micronutrient deficiency; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,000,000.00 | 69 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support the engagement of private providers for TB control in Mumbai via an innovative ‘interface agency’ model, and eventually integrate the interface agency services into routine TB program operations; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 29,308,395.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify and develop a Group B streptococcus glyco-conjugate vaccine candidate by an African vaccine manufacturer.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 4,150,332.00 | 66 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support translation of evidence around new approaches (as well as existing and new tools) for elimination into actionable and fundable strategies, plans, and measurable impact in Ethiopia and Senegal; Aid type: Project-type interventions. Affected countries: Ethiopia|Senegal. | |
| Bill and Melinda Gates Foundation | -281,390.00 | 346 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide the China National Program Management Office (NPMO) and the National Tuberculosis Reference Lab (NTRL) with technical assistance to ensure effective implementation of the China-Gates Foundation Tuberculosis Phase 2 project; Aid type: Other technical assistance. Affected countries: China. | |
| Bill and Melinda Gates Foundation | 281,390.00 | 224 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide overall project management and technical assistance to local organizations to improve TB control and prevention in China; Aid type: Other technical assistance. Affected countries: China. | |
| Bill and Melinda Gates Foundation | -21,943.00 | 328 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide technical and managerial support to expand the adoption of live attenuated SA 14-14-2 Japanese Encephalitis (JE) vaccine and scale up the Expanded Program for Immunization (EPI) in the JE-endemic districts of India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 21,943.00 | 297 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide technical support to the governments of Bihar and Uttar Pradesh for reduction in Case Fatality Rate due to encephalopathy and Acute Encephalitis Syndrome; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 42,431,110.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support and oversee development of a genetically-stabilized, low-cost novel OPV2 vaccine for use in outbreak control.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 55,249.53 | 290 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 78,512.49 | 279 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 78,512.49 | 279 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 78,512.49 | 279 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 809,506.00 | 168 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to focus on innovation introduction and reducing policy barriers to service delivery implementation; Aid type: Project-type interventions. Affected regions: Europe; affected countries: Kenya|Zambia|United states of america (the)|United kingdom of great britain and northern ireland (the)|Congo (the democratic republic of the)|South africa. | |
| Bill and Melinda Gates Foundation | 127,452.00 | 257 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to implement Projecting Health, a community-led video education project, enabling a cluster-randomized trial to evaluate the impact of the intervention on immunization coverage in Uttar Pradesh, India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 127,452.00 | 257 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to implement Projecting Health, a community-led video education project, enabling a cluster-randomized trial to evaluate the impact of the intervention on immunization coverage in Uttar Pradesh, India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 2,595,171.00 | 90 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the organization and execution of a convening of rotavirus experts, who gather, aggregate, and package existing data around optimal use of rotavirus vaccine for presentation to the WHO's Strategic Advisory Group of Experts (SAGE); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 32,033,228.00 | 8 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate that subnational malaria elimination is feasible in an endemic country in sub-Saharan Africa using available tools in new ways; Aid type: Project-type interventions. Affected countries: Zambia. | |
| Bill and Melinda Gates Foundation | 5,000.00 | 302 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. 2016 Breakfast for Global Health. Investment start date: 4/14/2016 to end date: 5/20/2016. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -4,681.46 | 321 | Global health/Medical education/training | https://iatiregistry.org/publisher/bmgf | -- | to enable dramatic, scalable and sustainable improvements in global health by the year 2030 through increasing broader awareness and learning of the potentially game-changing innovations.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 79,977.00 | 278 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to conduct interviews, assess, and make recommendations on increasing the support capacity for the development, implementation, and support services for the District Health Information System; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,000,000.00 | 30 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support the Reach Campaign focusing on the areas of greatest disparity and potential impact including malaria elimination, women's and reproductive health, maternal and newborn health, and child health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. Starting Gates Thank You Award March 2016. Investment start date: 3/24/2016 to end date: 4/15/2016. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 1,250,000.00 | 132 | Population | https://hewlett.org/grants/path-for-paths-reproductive-health-global-program-1/ | -- | For PATH's Reproductive Health Global Program. | |
| Hewlett Foundation | 1,250,000.00 | 132 | Population | https://hewlett.org/grants/path-for-paths-reproductive-health-global-program-1/ | -- | For PATH's Reproductive Health Global Program. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. Starting Gates Thank You Grant November 2015. Investment start date: 1/6/2016 to end date: 1/7/2016. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 10,616,881.00 | 26 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,000,000.00 | 83 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support activities critical to access and availability of infection detection interventions and future malaria diagnostic tests for elimination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,499,160.00 | 80 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop adjuvanted formulations of vaccine with the ultimate goal of accelerating the development and introduction of efficacious vaccines against deadly infectious diseases in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,928,780.00 | 24 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to enable development of the Vaccine Development and Introduction Platforms, which will position PATH to evaluate and progress a robust pipeline of global health vaccine projects from product concept to impact with industry-standard quality, speed, and ef; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,869,766.00 | 71 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to focus on innovation introduction and reducing policy barriers to service delivery implementation; Aid type: Project-type interventions. Affected regions: Europe; affected countries: Kenya|Zambia|United states of america (the)|United kingdom of great britain and northern ireland (the)|Congo (the democratic republic of the)|South africa. | |
| Bill and Melinda Gates Foundation | 662,754.58 | 179 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 941,809.14 | 154 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 941,809.14 | 154 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 941,809.14 | 154 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To address market challenges in for HPV/cervical cancer treatment, glucose-6-phosphate dehydrogenase diagnostic tests and O2/oxygen concentrators for pneumonia; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,760,000.00 | 88 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for clinical development of the RTS,S, malaria vaccine. PATH - Malaria Vaccine Initiative Clinical Development by the Malaria Vaccine Initiative of RTS,S, a Malaria Vaccine [PDW]. Investment start date: 6/1/2009 to end date: 12/31/2019. Grantee name: PAT; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,050,000.00 | 146 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advance the availability and uptake of programmatically suitable tools to improve the efficiency of data-driven vaccination systems in collaboration with country and global stakeholders; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,800,000.00 | 109 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide overall project management and technical assistance to local organizations to improve TB control and prevention in China; Aid type: Other technical assistance. Affected countries: China. | |
| Bill and Melinda Gates Foundation | 2,500,000.00 | 92 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to improve health outcomes by strengthening national health information systems and data use in key countries, building evidence of data systems and use practices that improve health outcomes; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: Tanzania, united republic of. | |
| Bill and Melinda Gates Foundation | 8,776,572.00 | 38 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to collaborate with four sub-Saharan African countries with diverse malaria transmission patterns to demonstrate the feasibility of malaria elimination in the near term given sufficient resources and political commitment; Aid type: Project-type interventions. Affected countries: Senegal|Kenya|Zambia|Ethiopia. | |
| Bill and Melinda Gates Foundation | 28,066.00 | 295 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate a reduction in global cervical cancer incidence and mortality by helping countries with a high burden of cervical cancer introduce new screening technologies and cervical cancer prevention best practices; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 1,576,918.00 | 114 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide technical support to the governments of Bihar and Uttar Pradesh for reduction in Case Fatality Rate due to encephalopathy and Acute Encephalitis Syndrome; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | -1,037.14 | 316 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support a project to conduct a detailed market analysis in Nigeria and Burkina Faso to understand user and health provider experience in treating diarrhea/pneumonia; Aid type: Project-type interventions. Affected countries: Burkina faso|Nigeria. | |
| Bill and Melinda Gates Foundation | -274,107.00 | 345 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish Institute for One World Health as an affiliated organization benefiting from PATH’s infrastructure; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -508,000.00 | 348 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to promote evidence-based advocacy that will improve health in low-resource settings, particularly in the priorities identified by the health-focused Millennium Development Goals; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -224,027.00 | 342 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish Institute for One World Health as an affiliated organization benefiting from PATH’s infrastructure; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 405,750.00 | 204 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and update an assessment framework for the long-term viability of vaccine manufacturers for the traditional Expanded Program on Immunization vaccines and insights into factors that influence their success; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,896,046.00 | 62 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to maximize the impact of the Ethiopia iCCM execution plan that will be jointly developed by both partners in close collaboration with the Ethiopian government; Aid type: Project-type interventions. Affected countries: Ethiopia. | |
| Bill and Melinda Gates Foundation | -9,303.98 | 322 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to scale up coverage of effective interventions and by disseminating operational guidance to inform the policies and practices of donors, implementing partners, and national governments; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -4,275,566.00 | 359 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and commercialize a new formulation of oral rehydration solution (ORS), one that addresses the symptoms as well as the dehydration caused by diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 508,000.00 | 192 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to focus on innovation introduction and reducing policy barriers to service delivery implementation; Aid type: Project-type interventions. Affected regions: Europe; affected countries: Kenya|Zambia|United states of america (the)|United kingdom of great britain and northern ireland (the)|Congo (the democratic republic of the)|South africa. | |
| Bill and Melinda Gates Foundation | 149,568.00 | 250 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the development of a country-owned national health information system to improve the immunization supply chain and cold chain in Tanzania; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -1,201,068.00 | 354 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and commercialize a new formulation of oral rehydration solution (ORS), one that addresses the symptoms as well as the dehydration caused by diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -55,838.81 | 333 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to assess the performance of HIV RDT with non expert users and through guard band studies and to develop a target product profile for a future HIV self test in high burden areas of sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 940,168.00 | 157 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to generate a comprehensive evidence base for product development and strategic operations related to the efficient use of existing and new diagnostic technologies for malaria infection detection in near-elimination and elimination-phase programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -10,805.40 | 323 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the development of tools for polio virus detection and surveillance. Tools for Polio Virus Detection and Surveillance. Investment start date: 10/24/2011 to end date: 5/31/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,407,691.00 | 127 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to increase women’s access to safe, effective and discreet contraception by facilitating introduction and delivery of subcutaneous contraceptive (depo-subQ in uniject (Sayana Press)) through community, clinic and social marketing channels and undertaking ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 306,706.00 | 219 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish a home for cross-Product Development Partnership (PDP) regulatory support, and provide evidence that the model both strengthens regulatory capacity for PDP products and is more efficient than establishing resources at individual PDPs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 600,000.00 | 184 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify, evaluate, and apply platform vaccine formulation and stabilization technologies to accelerate the development and introduction of safe, efficacious, and programmatically suitable vaccines in low- to middle-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,000.00 | 302 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide general operating support. 2015 Breakfast for Global Health. Investment start date: 3/11/2015 to end date: 4/3/2015. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support the Starting Gates Partnership. Starting Gates 2/4/15. Investment start date: 2/11/2015 to end date: 3/5/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 136,031.00 | 253 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. General Operating Support. Investment start date: 2/10/2015 to end date: 9/30/2017. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support the Starting Gates partnership. Starting Gates 11/5/14. Investment start date: 1/28/2015 to end date: 2/12/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | -2,815,717.00 | 358 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide technical and managerial support to expand the adoption and scaling-up of an effective vaccine against Japanese encephalitis in endemic countries in the South-East Asia and Western Pacific regions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 8,192,753.00 | 40 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to reduce the morbidity and mortality of Japanese encephalitis (JE) and ensure that every child at risk of JE infection is protected by a safe, efficacious, and affordable vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -677,906.00 | 351 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support accelerating vaccine access for Japanese encephalitis. Japanese Encephalitis: Accelerating Vaccine Access. Investment start date: 11/1/2003 to end date: 1/31/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Cambodia|China|India|Korea (the republic of)|Sri lanka|Philippines (the)|Indonesia. | |
| Bill and Melinda Gates Foundation | 7,716,311.00 | 43 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to reduce the morbidity and mortality of Japanese encephalitis (JE) and ensure that every child at risk of JE infection is protected by a safe, efficacious, and affordable vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| MacArthur Foundation | 250,000.00 | 232 | FIXME | https://www.macfound.org/grants/ | -- | To support work on maternal health supplies by the Reproductive Health Supplies Coalition (over two years). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Bill and Melinda Gates Foundation | 10,234,086.00 | 28 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 6,985,379.00 | 48 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to advance the availability and uptake of programmatically suitable tools to improve the efficiency of data-driven vaccination systems in collaboration with country and global stakeholders; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 300,000.00 | 220 | Global development/Promotion of development awareness (non-sector allocable) | https://iatiregistry.org/publisher/bmgf | -- | to provide technical assistance for guideline development on Human Milk Banking in India; Aid type: Development awareness. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 2,545,834.00 | 91 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make available a rapid, affordable, and field-friendly Ov-16 antigen-based antibody test (“Ov-16 rapid test”) for use in onchocerciasis programs for disease control and eventual elimination in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 271,665.00 | 226 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support the work of the Alliance for Reproductive Maternal Newborn Health Secretariat to accelerate progress towards Millennium Development Goals (MDGs) 4 and 5 and document the results once the partnership is complete in September 2015; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,989,166.00 | 58 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to contribute to the elimination of meningococcal meningitis epidemics as a public health problem in sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 17,166,694.00 | 19 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to focus on innovation introduction and reducing policy barriers to service delivery implementation; Aid type: Project-type interventions. Affected regions: Europe; affected countries: Kenya|Zambia|United states of america (the)|United kingdom of great britain and northern ireland (the)|Congo (the democratic republic of the)|South africa. | |
| Bill and Melinda Gates Foundation | 10,851,639.00 | 25 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to increase the evidence base regarding the efficacy of vaccination of women during pregnancy against pertussis, thereby supporting efforts to make available a potentially high-impact intervention to reduce pertussis in mothers and newborns; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: Zambia|Pakistan. | |
| Bill and Melinda Gates Foundation | 9,134,534.00 | 36 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development and availability of point-of-care diagnostic tests for G6PD deficiency that ensure that this class of drugs can be safely distributed in low-resource settings where P. vivax is most endemic and has the largest economic and he; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 750,000.00 | 173 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop evidence for improving the performance of live, attenuated, orally delivered rotavirus vaccines in infants in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 256,509.00 | 229 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to identify and advance a low-cost point-of-care diagnostic system to test donor milk for microbial contamination; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 671,360.00 | 178 | Agriculture/agricultural development | https://iatiregistry.org/publisher/bmgf | -- | to improve livestock diagnostics tools for use by smallholder farmers in low and middle-income countries by undertaking a landscape analysis of livestock diagnostics and recommending a broader investment strategy aimed at furthering the field of livestock; Aid type: Project-type interventions. Affected regions: Asia|Africa. | |
| Bill and Melinda Gates Foundation | 156,144,866.00 | 2 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of malaria vaccines that meet the needs of malaria-endemic countries.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500,000.00 | 193 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide the China National Program Management Office (NPMO) and the National Tuberculosis Reference Lab (NTRL) with technical assistance to ensure effective implementation of the China-Gates Foundation Tuberculosis Phase 2 project; Aid type: Other technical assistance. Affected countries: China. | |
| Bill and Melinda Gates Foundation | 250,000.00 | 232 | Global health/Medical education/training | https://iatiregistry.org/publisher/bmgf | -- | to enable dramatic, scalable and sustainable improvements in global health by the year 2030 through increasing broader awareness and learning of the potentially game-changing innovations.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 287,759.00 | 223 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the elimination of epidemic meningitis in Sub-Saharan Africa. PATH - Meningitis Vaccine Project (MVP). Investment start date: 6/30/2001 to end date: 7/29/2016. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 129,725.00 | 256 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to contribute to a better understanding of what will be required to lead to malaria elimination in El Salvador; Aid type: Project-type interventions. Affected countries: El salvador. | |
| Bill and Melinda Gates Foundation | 2,244,357.00 | 101 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,581,365.00 | 113 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to collaborate with four sub-Saharan African countries with diverse malaria transmission patterns to demonstrate the feasibility of malaria elimination in the near term given sufficient resources and political commitment; Aid type: Project-type interventions. Affected countries: Senegal|Kenya|Zambia|Ethiopia. | |
| Bill and Melinda Gates Foundation | 175,000.00 | 244 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to carry out a systematic analysis of the global market for cryotechnologies to determine if there are market shortcomings, and if so, the nature of those shortcomings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 251,149.00 | 231 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to conduct a landscape analysis assessing the current knowledge gaps, operational barriers, and opportunities for implementing antenatal pertussis immunization programs in low-resource countries.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -315,705.00 | 347 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to build developing country capacity to prevent cervical cancer. The START-UP Project: Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning. Investment start date: 11/29/2007 to end date: 6/30/2013. G; Aid type: Other technical assistance. Affected countries: Nicaragua|Uganda|India. | |
| Bill and Melinda Gates Foundation | 315,705.00 | 217 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate a reduction in global cervical cancer incidence and mortality by helping countries with a high burden of cervical cancer introduce new screening technologies and cervical cancer prevention best practices; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 400,000.00 | 205 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide quantified sample panels to diagnostic test developers being funded by the Bill & Melinda Gates Foundation and perform unbiased evaluations and appraisals of diagnostic technologies upon request; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500,000.00 | 193 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop adjuvanted formulations of vaccine with the ultimate goal of accelerating the development and introduction of efficacious vaccines against deadly infectious diseases in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 112,332.00 | 261 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support a project to conduct a detailed market analysis in Nigeria and Burkina Faso to understand user and health provider experience in treating diarrhea/pneumonia; Aid type: Project-type interventions. Affected countries: Burkina faso|Nigeria. | |
| Bill and Melinda Gates Foundation | 1,207,083.00 | 139 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to build consensus on the vaccine impact methodology and study design and maintain the surveillance and infrastructure at the GEMS sites in this interim period before the impact studies begin; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,492,354.00 | 81 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to address the gaps in Neglected Tropical Diseases (NTD) diagnostics by catalyzing the diagnostics industry to advance the development and commercialization of new diagnostic tools needed by the NTD community. More sensitive and specific tools are require; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -20,430.99 | 327 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support participation of investigators at an international conference on new developments in vaccines for enteric diseases of global public health significance; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 47,000.00 | 292 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support a project to improve uptake of Malaria in Pregnancy (MiP) interventions; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -47,000.00 | 332 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve maternal health and survival and reduce the incidence of postpartum hemorrhage (PPH) in resource-poor settings through enhanced political will and improved access to oxytocin, a key lifesaving intervention for routine prevention of PPH; Aid type: Project-type interventions. Affected countries: India|Zambia|Ghana. | |
| Bill and Melinda Gates Foundation | 311,212.00 | 218 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish a home for cross-Product Development Partnership (PDP) regulatory support, and provide evidence that the model both strengthens regulatory capacity for PDP products and is more efficient than establishing resources at individual PDPs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,860,000.00 | 63 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 264 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide the China National Program Management Office (NPMO) and the National Tuberculosis Reference Lab (NTRL) with technical assistance to ensure effective implementation of the China-Gates Foundation Tuberculosis Phase 2 project; Aid type: Other technical assistance. Affected countries: China. | |
| Bill and Melinda Gates Foundation | 10,000,000.00 | 30 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support PATH’s next phase of infrastructure that will support the discovery, development and delivery of global health interventions to those who need them most; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,000.00 | 300 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. 2014 Breakfast for Global Health. Investment start date: 4/24/2014 to end date: 5/9/2014. Grantee name: PATH; Aid type: Contributions to specific-purpose programmes and funds managed by implementing partners. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 996,595.00 | 152 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to understand the need and necessary inputs for the development of a reliable, robust, and scalable oxygen concentrator platform technology to accelerate oxygen delivery in low-resource settings.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -820.76 | 315 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | To improve the health of vulnerable infants through access to safe donor milk is the goal of this project. This award will fund a convening of international human milk banking experts to create a global implementation framework.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. Starting Gates 3/12/14. Investment start date: 3/19/2014 to end date: 4/4/2014. Grantee name: PATH; Aid type: Contributions to specific-purpose programmes and funds managed by implementing partners. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | -1,769.13 | 317 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and field test a durable liner for vaccine carriers to protect vaccines from freezing.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -4,560.80 | 320 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use of bar code technology to improve vaccine supply and logistics management as well as strategic forecasting of vaccine supply and demand.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -658.02 | 314 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop and test a low-cost, cell-phone-based networked sensing system to provide safety monitoring of low-technology flash- heating pasteurization of breast milk designated for donation.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 943,879.00 | 153 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the evaluation of rapid tests for glucose-6-phosphate dehydrogenase enzyme deficiency to support Plasmodium vivax malaria drug delivery in low-resource settings; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 7,112,910.00 | 47 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 29,879,739.00 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to collaborate with four sub-Saharan African countries with diverse malaria transmission patterns to demonstrate the feasibility of malaria elimination in the near term given sufficient resources and political commitment; Aid type: Project-type interventions. Affected countries: Senegal|Kenya|Zambia|Ethiopia. | |
| Bill and Melinda Gates Foundation | -26,668.29 | 330 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support guiding the proactive introduction of multiple vaccines in GAVI-eligible countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,000,000.00 | 30 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to reduce the incidence and mortality of cervical cancer caused by human papillomavirus (HPV) infection by helping establish routine use of effective HPV-DNA screening tests in countries with high burdens of disease; Aid type: Project-type interventions. Affected regions: Africa|Developing countries, unspecified; affected countries: Guatemala|Honduras|Nicaragua|El salvador. | |
| Bill and Melinda Gates Foundation | 6,840,000.00 | 50 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to promote early TB diagnosis and accountable treatment for patients seeking care from private health care sector outlets in Mumbai; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 776,948.00 | 172 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop technical resource materials, including operational and training guidelines and tools, to support the introduction of rotavirus vaccine in low-resource settings, including countries that meet guidelines for support by GAVI, as well as develop s; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: India. | |
| Bill and Melinda Gates Foundation | 998,543.00 | 150 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to develop and test a low-cost, cell-phone-based networked sensing system to provide safety monitoring of low-technology flash- heating pasteurization of breast milk designated for donation. The goal is to scale-up human milk banking for vulnerable infant; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 474,968.00 | 200 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to carry out a systematic analysis of the global market for cryotechnologies to determine if there are market shortcomings, and if so, the nature of those shortcomings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,467,791.00 | 125 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to build consensus on the vaccine impact methodology and study design and maintain the surveillance and infrastructure at the GEMS sites in this interim period before the impact studies begin; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 998,287.00 | 151 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to prevent freezing of vaccines through a new class of passive cold chain equipment; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: Senegal|China|India. | |
| Bill and Melinda Gates Foundation | 105,901.00 | 263 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support participation of investigators at an international conference on new developments in vaccines for enteric diseases of global public health significance; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -799,093.00 | 352 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the continuation and expansion of the work of the Malaria Vaccine Initiative; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 799,093.00 | 170 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of promising malaria vaccines and to ensure their availability and accessibility in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 883,724.00 | 163 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support accelerating vaccine access for Japanese encephalitis. Japanese Encephalitis: Accelerating Vaccine Access. Investment start date: 11/1/2003 to end date: 1/31/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Cambodia|China|India|Korea (the republic of)|Sri lanka|Philippines (the)|Indonesia. | |
| Bill and Melinda Gates Foundation | 182,928.00 | 243 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the development of tools for polio virus detection and surveillance. Tools for Polio Virus Detection and Surveillance. Investment start date: 10/24/2011 to end date: 5/31/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 271,570.00 | 227 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate a reduction in global cervical cancer incidence and mortality by helping countries with a high burden of cervical cancer introduce new screening technologies and cervical cancer prevention best practices; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | -271,570.00 | 344 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to strengthen the capability of developing countries to reduce cervical cancer incidence and deaths; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,548,599.00 | 116 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide technical and managerial support to expand the adoption of live attenuated SA 14-14-2 Japanese Encephalitis (JE) vaccine and scale up the Expanded Program for Immunization (EPI) in the JE-endemic districts of India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 1,864,094.00 | 107 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make available a rapid, affordable, and field-friendly Ov-16 antigen-based antibody test (“Ov-16 rapid test”) for use in onchocerciasis programs for disease control and eventual elimination in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 19,500,000.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To achieve sustained increases in immunization coverage through support for country-owned, country-led policies, practices, and information system tools that enable evidence-based decision-making.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,797,275.00 | 110 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to ensure that vaccine products, packaging, delivery devices, and cold chain equipment incorporate features to reduce total systems costs, ease logistics, improve safety, maximize access and meet needs of developing-country immunization programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 369,712.00 | 209 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish a home for cross-Product Development Partnership (PDP) regulatory support, and provide evidence that the model both strengthens regulatory capacity for PDP products and is more efficient than establishing resources at individual PDPs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 1,250,000.00 | 132 | Population | https://hewlett.org/grants/path-for-paths-reproductive-health-global-program-0/ | -- | For PATH's Reproductive Health Global Program. | |
| Hewlett Foundation | 1,250,000.00 | 132 | Population | https://hewlett.org/grants/path-for-paths-reproductive-health-global-program-0/ | -- | For PATH's Reproductive Health Global Program. | |
| Bill and Melinda Gates Foundation | 9,000,000.00 | 37 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to develop the capacity of the Reproductive Health Supply coalition. RHSC - Reproductive Health Supplies Coalition Secretariat. Investment start date: 2/20/2013 to end date: 6/30/2018. Grantee name: PATH; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 10,106,727.00 | 29 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to increase women’s access to safe, effective and discreet contraception by facilitating introduction and delivery of subcutaneous contraceptive (depo-subQ in uniject (Sayana Press)) through community, clinic and social marketing channels and undertaking ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,139,525.00 | 142 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support a project to conduct a detailed market analysis in Nigeria and Burkina Faso to understand user and health provider experience in treating diarrhea/pneumonia; Aid type: Project-type interventions. Affected countries: Burkina faso|Nigeria. | |
| Bill and Melinda Gates Foundation | 84,313.00 | 276 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to promote evidence-based advocacy that will improve health in low-resource settings, particularly in the priorities identified by the health-focused Millennium Development Goals; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -84,313.00 | 336 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to advocate for building support for microbicde advocacy. Global Campaign for Microbicides. Investment start date: 7/9/2009 to end date: 1/31/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: South africa|Kenya. | |
| Bill and Melinda Gates Foundation | 136,000.00 | 254 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support guiding the proactive introduction of multiple vaccines in GAVI-eligible countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -95,200.00 | 338 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support the Children's Vaccine Program. Children's Vaccine Program. Investment start date: 8/26/1998 to end date: 12/31/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: India. | |
| Bill and Melinda Gates Foundation | -27,200.00 | 331 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the Children's Vaccine Program. Children's Vaccine Program. Investment start date: 8/26/1998 to end date: 12/31/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: India. | |
| Bill and Melinda Gates Foundation | -13,600.00 | 326 | Global health/Health personnel development | https://iatiregistry.org/publisher/bmgf | -- | to support the Children's Vaccine Program. Children's Vaccine Program. Investment start date: 8/26/1998 to end date: 12/31/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: India. | |
| Bill and Melinda Gates Foundation | 1,845,630.00 | 108 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide for general operating support. PATH Institutional Support Grant. Investment start date: 11/21/2012 to end date: 12/31/2020. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,500,000.00 | 78 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide technical and managerial support to expand the adoption and scaling-up of an effective vaccine against Japanese encephalitis in endemic countries in the South-East Asia and Western Pacific regions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,088,252.00 | 145 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide accurate and current information on the expected impact of rotavirus vaccination in India in order to assist planning for the introduction and rollout of rotavirus vaccines; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 2,325,773.00 | 100 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop an affordable, easy-to-use, and effective stable liquid multi-dose rotavirus vaccine delivery system for introduction to vaccine partners in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 599,909.00 | 188 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support a project to improve uptake of Malaria in Pregnancy (MiP) interventions; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 500.00 | 305 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. StartingGates 9/5/12. Investment start date: 10/29/2012 to end date: 11/15/2012. Grantee name: PATH; Aid type: Development awareness. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,111,031.00 | 143 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to conduct an independent third-party evaluation of three technologies for their appropriateness as potential typhoid surveillance tools and to assess their readiness to go into a three-way head-to-head field evaluation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,499,500.00 | 124 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support a project to reduce adverse outcomes for pregnant women and newborns due to congenital syphilis and other maternal infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Nigeria|Ethiopia|India. | |
| Bill and Melinda Gates Foundation | 1,336,680.00 | 129 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve maternal health and survival and reduce the incidence of postpartum hemorrhage (PPH) in resource-poor settings through enhanced political will and improved access to oxytocin, a key lifesaving intervention for routine prevention of PPH; Aid type: Project-type interventions. Affected countries: India|Zambia|Ghana. | |
| Bill and Melinda Gates Foundation | 2,778,517.00 | 87 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to scale up coverage of effective interventions and by disseminating operational guidance to inform the policies and practices of donors, implementing partners, and national governments; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 3,786,841.00 | 75 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to generate a comprehensive evidence base for product development and strategic operations related to the efficient use of existing and new diagnostic technologies for malaria infection detection in near-elimination and elimination-phase programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,123,674.00 | 67 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate a reduction in global cervical cancer incidence and mortality by helping countries with a high burden of cervical cancer introduce new screening technologies and cervical cancer prevention best practices; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 195,817.00 | 241 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | To improve the health of vulnerable infants through access to safe donor milk is the goal of this project. This award will fund a convening of international human milk banking experts to create a global implementation framework.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 275,000.00 | 225 | Population | https://hewlett.org/grants/path-for-support-of-paths-francophone-african-forum-focusing-on-contraceptive-security/ | -- | For Support Of PATH’s Francophone African Forum Focusing On Contraceptive Security. | |
| Bill and Melinda Gates Foundation | 242,381.00 | 237 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the development of tools for polio virus detection and surveillance. Tools for Polio Virus Detection and Surveillance. Investment start date: 10/24/2011 to end date: 5/31/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,296,332.00 | 131 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to provide the China National Program Management Office (NPMO) and the National Tuberculosis Reference Lab (NTRL) with technical assistance to ensure effective implementation of the China-Gates Foundation Tuberculosis Phase 2 project; Aid type: Other technical assistance. Affected countries: China. | |
| Bill and Melinda Gates Foundation | 86,636.00 | 273 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop multi-dose, needle-free jet injectors to facilitate the delivery of mass immunization; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 852,477.00 | 164 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to shape the future of supply and delivery systems for vaccines and other health products in low- and middle-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,413,300.00 | 126 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to promote policy change and increased resources to accelerate access to new global health technologies to reduce the rates of morbidity and mortality in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 264 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and field test a durable liner for vaccine carriers to protect vaccines from freezing.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 131,504.00 | 255 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support accelerating vaccine access for Japanese encephalitis. Japanese Encephalitis: Accelerating Vaccine Access. Investment start date: 11/1/2003 to end date: 1/31/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Cambodia|China|India|Korea (the republic of)|Sri lanka|Philippines (the)|Indonesia. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 264 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use of bar code technology to improve vaccine supply and logistics management as well as strategic forecasting of vaccine supply and demand.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 50,387.00 | 291 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make available a rapid, affordable, and field-friendly Ov-16 antigen-based antibody test (“Ov-16 rapid test”) for use in onchocerciasis programs for disease control and eventual elimination in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| MacArthur Foundation | 300,000.00 | 220 | FIXME | https://www.macfound.org/grants/ | -- | In support of work on maternal health supplies by the Reproductive Health Supplies Coalition (over two years). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Bill and Melinda Gates Foundation | 3,864,027.00 | 72 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish Institute for One World Health as an affiliated organization benefiting from PATH’s infrastructure; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 9,875,996.00 | 34 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop and commercialize a new formulation of oral rehydration solution (ORS), one that addresses the symptoms as well as the dehydration caused by diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,839,143.00 | 74 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop evidence for improving the performance of live, attenuated, orally delivered rotavirus vaccines in infants in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,223,356.00 | 138 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to assess the performance of HIV RDT with non expert users and through guard band studies and to develop a target product profile for a future HIV self test in high burden areas of sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 6,955,881.00 | 49 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop adjuvanted formulations of vaccine with the ultimate goal of accelerating the development and introduction of efficacious vaccines against deadly infectious diseases in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 636,949.00 | 181 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the development of tools for polio virus detection and surveillance. Tools for Polio Virus Detection and Surveillance. Investment start date: 10/24/2011 to end date: 5/31/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -4,206.00 | 319 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to ensure broad participation by African researchers at the International Rotavirus Symposium in Johannesburg and the related African Rotavirus Symposium through PATH-directed support to conference hosts; Aid type: Project-type interventions. Affected regions: Africa|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 264 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop and test a low-cost, cell-phone-based networked sensing system to provide safety monitoring of low-technology flash- heating pasteurization of breast milk designated for donation.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,205,633.00 | 140 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the evaluation of rapid tests for glucose-6-phosphate dehydrogenase enzyme deficiency to support Plasmodium vivax malaria drug delivery in low-resource settings; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 438,179.00 | 203 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to advocate for building support for microbicde advocacy. Global Campaign for Microbicides. Investment start date: 7/9/2009 to end date: 1/31/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: South africa|Kenya. | |
| Bill and Melinda Gates Foundation | 14,719,732.00 | 23 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to promote evidence-based advocacy that will improve health in low-resource settings, particularly in the priorities identified by the health-focused Millennium Development Goals; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,000,000.00 | 21 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support a capital campaign. Reach Campaign. Investment start date: 7/12/2011 to end date: 6/30/2016. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa; affected countries: United states of america (the)|China. | |
| Bill and Melinda Gates Foundation | 1,500,000.00 | 118 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support the Reproductive Health Supplies Coalition (RHSC). Reproductive Health Supplies Coalition and Alliance for Reproductive Health. Investment start date: 3/1/2006 to end date: 11/28/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,854,562.00 | 73 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to develop and test a commercial model for the scale-up of fortified rice. Ultra Rice Roll-Out and Technology Transfer: Fortified Rice for the Developing World-PHASE THREE. Investment start date: 6/1/2011 to end date: 9/30/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 75,138.00 | 282 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support a market research study in India and East Africa to identifing target product profiles for improved oral rehydration salts and zinc , and will begin to align stakeholders towards the goal of sustained public health impact; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: India. | |
| Bill and Melinda Gates Foundation | 75,138.00 | 282 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support a market research study in India and East Africa to identifing target product profiles for improved oral rehydration salts and zinc , and will begin to align stakeholders towards the goal of sustained public health impact; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: India. | |
| Bill and Melinda Gates Foundation | 600,000.00 | 184 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support the Reproductive Health Supplies Coalition (RHSC). Reproductive Health Supplies Coalition and Alliance for Reproductive Health. Investment start date: 3/1/2006 to end date: 11/28/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,356,234.00 | 99 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support accelerating vaccine access for Japanese encephalitis. Japanese Encephalitis: Accelerating Vaccine Access. Investment start date: 11/1/2003 to end date: 1/31/2015. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Cambodia|China|India|Korea (the republic of)|Sri lanka|Philippines (the)|Indonesia. | |
| Bill and Melinda Gates Foundation | -153,178.98 | 340 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to compare options for home-based management of severe acute malnutrition in children in India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | -300.00 | 312 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to ensure broad participation by African researchers at the International Rotavirus Symposium in Johannesburg and the related African Rotavirus Symposium through PATH-directed support to conference hosts; Aid type: Project-type interventions. Affected regions: Africa|Developing countries, unspecified. | |
| MacArthur Foundation | 115,000.00 | 260 | FIXME | https://www.macfound.org/grants/ | -- | To support the manufacture and scale-up of the AntiShock Garment for reduction of deaths from postpartum hemorrhage (over 15 months). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Bill and Melinda Gates Foundation | 887,850.00 | 162 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to establish a home for cross-Product Development Partnership (PDP) regulatory support, and provide evidence that the model both strengthens regulatory capacity for PDP products and is more efficient than establishing resources at individual PDPs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 724,266.00 | 175 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support a market research study in India and East Africa to identifing target product profiles for improved oral rehydration salts and zinc , and will begin to align stakeholders towards the goal of sustained public health impact; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: India. | |
| Bill and Melinda Gates Foundation | 724,266.00 | 175 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support a market research study in India and East Africa to identifing target product profiles for improved oral rehydration salts and zinc , and will begin to align stakeholders towards the goal of sustained public health impact; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: India. | |
| Bill and Melinda Gates Foundation | 4,999,724.00 | 57 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop evidence for improving the performance of live, attenuated, orally delivered rotavirus vaccines in infants in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,056,772.00 | 82 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make available a rapid, affordable, and field-friendly Ov-16 antigen-based antibody test (“Ov-16 rapid test”) for use in onchocerciasis programs for disease control and eventual elimination in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,370,050.00 | 128 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support limited introduction of Depo SubQ in the Uniject device. Accelerated Introduction of Depo SubQ in the Uniject Device. Investment start date: 11/15/2008 to end date: 6/30/2013. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: South & Central Asia|South of Sahara. | |
| Bill and Melinda Gates Foundation | 17,232,724.00 | 18 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the elimination of epidemic meningitis in Sub-Saharan Africa. PATH - Meningitis Vaccine Project (MVP). Investment start date: 6/30/2001 to end date: 7/29/2016. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 1,198,870.00 | 141 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to understand the intensity of transmission as malaria control increases and the impact on clinical trials for new tools; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -615.00 | 313 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to complete a study of pneumococcal conjugate vaccine for children in the Philippines; Aid type: Project-type interventions. Affected countries: Philippines (the). | |
| Bill and Melinda Gates Foundation | 66,700.00 | 284 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to ensure broad participation by African researchers at the International Rotavirus Symposium in Johannesburg and the related African Rotavirus Symposium through PATH-directed support to conference hosts; Aid type: Project-type interventions. Affected regions: Africa|Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,000,000.00 | 148 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. General Operating Support. Investment start date: 6/21/2010 to end date: 6/23/2011. Grantee name: PATH; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 46,511,826.00 | 5 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to scale up coverage of effective interventions and by disseminating operational guidance to inform the policies and practices of donors, implementing partners, and national governments; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | -11,882,537.00 | 361 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the Malaria Control and Evaluation Program in Africa. Malaria Control and Evaluation Partnership in Africa (MACEPA). Investment start date: 10/10/2004 to end date: 9/15/2010. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa; affected countries: Zambia. | |
| Bill and Melinda Gates Foundation | -5,468,446.00 | 360 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the Malaria Control and Evaluation Program in Africa. Malaria Control and Evaluation Partnership in Africa (MACEPA). Investment start date: 7/23/2007 to end date: 9/15/2010. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | -1,696,060.00 | 357 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the Malaria Control and Evaluation Program in Africa. Malaria Control and Evaluation Partnership in Africa (MACEPA). Investment start date: 7/23/2007 to end date: 9/15/2010. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | -27,464,783.00 | 363 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support a project to establish a regional learning community among certain African countries and develop a set of practices for scaling malaria control for impact; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 600,000.00 | 184 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support the Reproductive Health Supplies Coalition (RHSC). Reproductive Health Supplies Coalition and Alliance for Reproductive Health. Investment start date: 3/1/2006 to end date: 11/28/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 1,250,000.00 | 132 | Population | https://hewlett.org/grants/path-for-paths-reproductive-health-global-program/ | -- | For PATH's Reproductive Health Global Program. | |
| Bill and Melinda Gates Foundation | -200,000.00 | 341 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to build developing country capacity to prevent cervical cancer. The START-UP Project: Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning. Investment start date: 11/29/2007 to end date: 6/30/2013. G; Aid type: Other technical assistance. Affected countries: Nicaragua|Uganda|India. | |
| Bill and Melinda Gates Foundation | 2,500,000.00 | 92 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support a capital campaign for a new headquarters to meet PATH's long-term facilities needs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 187,177.00 | 242 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to compare options for home-based management of severe acute malnutrition in children in India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 499,752.00 | 196 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support guiding the proactive introduction of multiple vaccines in GAVI-eligible countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 7,985,377.00 | 42 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the regional elimination program in South Asia by getting a safe and effective treatment for visceral leishmaniasis, paromomycin intramuscular injection, registered and adopted by the governments of Bangladesh and Nepal; Aid type: Project-type interventions. Affected countries: Bangladesh|Nepal. | |
| Bill and Melinda Gates Foundation | 1,999,999.00 | 106 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the Countdown 2010 project which will promote sustained or increased commitment to malaria control by donor countries, international health organizations, and endemic/epidemic country governments; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,060,464.00 | 104 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support landscape diagnostic tools and treatments for maternal infections. Landscape Analysis of Maternal and Perinatal Infections. Investment start date: 11/16/2009 to end date: 6/30/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 100,000.00 | 264 | Population | https://hewlett.org/grants/path-for-developing-and-implementing-a-monitoring-and-evaluation-framework-system/ | -- | For Developing And Implementing A Monitoring And Evaluation Framework System. | |
| Bill and Melinda Gates Foundation | 4,980,764.00 | 60 | Global health/Health personnel development | https://iatiregistry.org/publisher/bmgf | -- | to design and develop a Phase 3 clinical trial training and mentorship program in India; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | -3,329.40 | 318 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to convene a meeting of global experts on diarrheal disease. Diarrheal Disease Control Consultative Meeting. Investment start date: 7/23/2007 to end date: 9/23/2007. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -24,975.97 | 329 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the "aids2031 Conference on Discovery and Innovation for HIV/AIDS" and the "aids2031 Conference on Product Development for HIV/AIDS"; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -13,432.78 | 324 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to improve the health status of youth in China. Improving Adolescent FP in China. Investment start date: 4/20/2000 to end date: 9/30/2008. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: China. | |
| Bill and Melinda Gates Foundation | -13,432.78 | 324 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve the health status of youth in China. Improving Adolescent FP in China. Investment start date: 4/20/2000 to end date: 9/30/2008. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: China. | |
| Bill and Melinda Gates Foundation | 1,500,000.00 | 118 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support the Reproductive Health Supplies Coalition (RHSC). Reproductive Health Supplies Coalition and Alliance for Reproductive Health. Investment start date: 3/1/2006 to end date: 11/28/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Ford Foundation | 100,000.00 | 264 | FIXME | http://www.fordfoundation.org/work/our-grants/grants-database/grants-all | -- | For research, public education, training and advocacy to promote public policies that address gender-based violence and feminicide in Nicaragua in coordination with regional organizations. Affected regions: 703###Nicaragua###100; 9177417###Female@@@; Mexico and Central America; affected countries: FIXME. | |
| Bill and Melinda Gates Foundation | 1,500,000.00 | 118 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to advocate for building support for microbicde advocacy. Global Campaign for Microbicides. Investment start date: 7/9/2009 to end date: 1/31/2012. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: South africa|Kenya. | |
| Ford Foundation | 394,542.00 | 208 | FIXME | http://www.fordfoundation.org/work/our-grants/grants-database/grants-all | -- | Final core support for the Global Campaign for Microbicides to educate the public about microbicides as a promising new technology to prevent HIV/AIDS and other sexually transmitted infections. Affected regions: 1110###Worldwide###100; 9177417###Female@@@9177456###No Intention@@@; United States; affected countries: FIXME. | |
| Bill and Melinda Gates Foundation | 75,141,981.00 | 4 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for clinical development of the RTS,S, malaria vaccine. PATH - Malaria Vaccine Initiative Clinical Development by the Malaria Vaccine Initiative of RTS,S, a Malaria Vaccine [PDW]. Investment start date: 6/1/2009 to end date: 12/31/2019. Grantee name: PAT; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,040,000.00 | 147 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support a Secretariat that coordinates Washington State Global Health Alliance activities; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,234,147.00 | 102 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to promote policy change and increased resources to accelerate access to new global health technologies to reduce the rates of morbidity and mortality in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| MacArthur Foundation | 400,000.00 | 205 | FIXME | https://www.macfound.org/grants/ | -- | To support the manufacture and scale-up of the AntiShock Garment for postpartum hemorrhage treatment. Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Bill and Melinda Gates Foundation | 2,999,663.00 | 84 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support limited introduction of Depo SubQ in the Uniject device. Accelerated Introduction of Depo SubQ in the Uniject Device. Investment start date: 11/15/2008 to end date: 6/30/2013. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: South & Central Asia|South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,999,242.00 | 85 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to build developing country capacity to prevent cervical cancer. The START-UP Project: Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning. Investment start date: 11/29/2007 to end date: 6/30/2013. G; Aid type: Other technical assistance. Affected countries: Nicaragua|Uganda|India. | |
| Bill and Melinda Gates Foundation | 999,942.00 | 149 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop the PATH Woman’s Condom, which offers an improvement in woman-initiated options for prevention of HIV and other sexually transmitted infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 9,680,781.00 | 35 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve maternal health and survival and reduce the incidence of postpartum hemorrhage (PPH) in resource-poor settings through enhanced political will and improved access to oxytocin, a key lifesaving intervention for routine prevention of PPH; Aid type: Project-type interventions. Affected countries: India|Zambia|Ghana. | |
| Bill and Melinda Gates Foundation | 143,502.00 | 251 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the "aids2031 Conference on Discovery and Innovation for HIV/AIDS" and the "aids2031 Conference on Product Development for HIV/AIDS"; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 168,731,146.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of promising malaria vaccines and to ensure their availability and accessibility in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 200,000.00 | 238 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop rapid HPV-testing technologies for cervical cancer prevention in developing countries; Aid type: Project-type interventions. Affected countries: India|China. | |
| Bill and Melinda Gates Foundation | 251,384.00 | 230 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support a Secretariat that coordinates Washington State Global Health Alliance activities; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 25,000.00 | 296 | Population | https://hewlett.org/grants/path-for-creating-a-business-plan-for-the-path-womans-condom-project/ | -- | For Creating A Business Plan For The PATH Woman's Condom Project. | |
| Bill and Melinda Gates Foundation | 34,690,601.00 | 7 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to shape the future of supply and delivery systems for vaccines and other health products in low- and middle-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 9,892,542.00 | 33 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop multi-dose, needle-free jet injectors to facilitate the delivery of mass immunization; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 25,027,211.00 | 15 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to maintain critical capacity to address global health problems with innovative technology solutions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,405,733.00 | 97 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to accelerate access to safe and effective microbicides. Global Campaign for Microbicides: Advocacy for Woman-controlled Prevention. Investment start date: 10/1/2007 to end date: 4/30/2009. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 510,937.00 | 191 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to increase the number of effective health care products delivered to the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 7,216,239.00 | 46 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to build developing country capacity to prevent cervical cancer. The START-UP Project: Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning. Investment start date: 11/29/2007 to end date: 6/30/2013. G; Aid type: Other technical assistance. Affected countries: Nicaragua|Uganda|India. | |
| Bill and Melinda Gates Foundation | 10,408,015.00 | 27 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the Malaria Control and Evaluation Program in Africa. Malaria Control and Evaluation Partnership in Africa (MACEPA). Investment start date: 7/23/2007 to end date: 9/15/2010. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 4,340,498.00 | 65 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the Malaria Control and Evaluation Program in Africa. Malaria Control and Evaluation Partnership in Africa (MACEPA). Investment start date: 7/23/2007 to end date: 9/15/2010. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 19,685.00 | 298 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to convene a meeting of global experts on diarrheal disease. Diarrheal Disease Control Consultative Meeting. Investment start date: 7/23/2007 to end date: 9/23/2007. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Ford Foundation | 296,773.00 | 222 | FIXME | http://www.fordfoundation.org/work/our-grants/grants-database/grants-all | -- | To develop and pilot a comprehensive, integrated model for strengthening the reproductive health & social service networks for migrant & other vulnerable women facing unplanned pregnancy in Thailand. Affected regions: 1007###Thailand###100; 9177417###Female@@@9177449###FOR-Foreign born; United States; affected countries: FIXME. | |
| Ford Foundation | 400,000.00 | 205 | FIXME | http://www.fordfoundation.org/work/our-grants/grants-database/grants-all | -- | Core support for the Global Campaign for Microbicides to educate the public about microbicides as a promising new technology to prevent HIV/AIDS and other sexually transmitted infections. Affected regions: 1110###Worldwide###100; 9177417###Female@@@9177456###No Intention@@@; United States; affected countries: FIXME. | |
| Bill and Melinda Gates Foundation | 679,990.00 | 177 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate a demand creation model to enhance NRHM services that saves newborn lives and reduces maternal mortality and morbidity in communities in India (Uttar Pradesh and Maharashtra); Aid type: Project-type interventions. Affected countries: India. | |
| Hewlett Foundation | 1,500,000.00 | 118 | Population | https://hewlett.org/grants/path-for-general-operating-support-of-paths-reproductive-health-strategic-program/ | -- | For General Operating Support Of PATH's Reproductive Health Strategic Program. | |
| Bill and Melinda Gates Foundation | 29,000,000.00 | 12 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support a project to establish a regional learning community among certain African countries and develop a set of practices for scaling malaria control for impact; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 24,602,129.00 | 16 | Water/basic drinking water supply | https://iatiregistry.org/publisher/bmgf | -- | to develop, model, evaluate, and introduce strategies for sustainably fulfilling global needs for safe water through household water treatment products; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa; affected countries: India|Cambodia|Viet nam. | |
| Bill and Melinda Gates Foundation | 29,288,864.00 | 11 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality in infants and children in Africa; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 1,562,727.00 | 115 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to strengthen contraceptive supply security in developing countries. Ensuring Contraceptive Supply Security. Investment start date: 10/1/2006 to end date: 9/30/2008. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,999,480.00 | 52 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to alleviate micronutrient deficiencies. Ultra Rice Roll-Out and Technology Transfer: Fortified Rice for the Developing World. Investment start date: 8/4/2006 to end date: 8/4/2011. Grantee name: PATH; Aid type: Project-type interventions. Affected countries: Brazil|China|India|Colombia. | |
| Bill and Melinda Gates Foundation | -20,949,155.00 | 362 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality in infants and children in Africa; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 27,844,078.00 | 14 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to strengthen the capability of developing countries to reduce cervical cancer incidence and deaths; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 7,341,131.00 | 44 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support the Reproductive Health Supplies Coalition (RHSC). Reproductive Health Supplies Coalition and Alliance for Reproductive Health. Investment start date: 3/1/2006 to end date: 11/28/2014. Grantee name: PATH; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Hewlett Foundation | 200,000.00 | 238 | Population | https://hewlett.org/grants/path-for-research-on-reproductive-health-technologies/ | -- | For Research On Reproductive Health Technologies. | |
| Hewlett Foundation | 925,000.00 | 158 | Population | https://hewlett.org/grants/path-for-general-support-of-paths-reproductive-health-strategic-program/ | -- | For General Support Of PATH's Reproductive Health Strategic Program. | |
| Hewlett Foundation | 625,000.00 | 182 | Population | https://hewlett.org/grants/path-for-general-support/ | -- | For General Support. | |
| Hewlett Foundation | 900,000.00 | 159 | Population | https://hewlett.org/grants/path-for-expansion-of-the-emergency-contraception-program/ | -- | For Expansion Of The Emergency Contraception Program. | |
| Hewlett Foundation | 900,000.00 | 159 | Population | https://hewlett.org/grants/path-for-expansion-of-the-emergency-contraception-program/ | -- | For Expansion Of The Emergency Contraception Program. | |
| MacArthur Foundation | 100,000.00 | 264 | FIXME | https://www.macfound.org/grants/ | -- | To support a project to encourage health reform efforts to address the reproductive health needs of married adolescents (over three years). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Andrew W. Mellon Foundation | 1,500,000.00 | 118 | Past Programs | https://mellon.org/grants/grants-database/grants/path/40100665/ | -- | Program name: Past Programs. | |
| Andrew W. Mellon Foundation | 600,000.00 | 184 | Past Programs | https://mellon.org/grants/grants-database/grants/path/10100716/ | -- | Program name: Past Programs. | |
| Hewlett Foundation | 1,100,000.00 | 144 | Population | https://hewlett.org/grants/path-for-general-support-0/ | -- | For General Support. | |
| Andrew W. Mellon Foundation | 500,000.00 | 193 | Past Programs | https://mellon.org/grants/grants-database/grants/path/19900649/ | -- | Program name: Past Programs. | |
| MacArthur Foundation | 250,000.00 | 232 | FIXME | https://www.macfound.org/grants/ | -- | To support the Women's Reproductive Health Initiative (over three years). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Andrew W. Mellon Foundation | 900,000.00 | 159 | Past Programs | https://mellon.org/grants/grants-database/grants/path/19800628/ | -- | Program name: Past Programs. | |
| MacArthur Foundation | 40,000.00 | 294 | FIXME | https://www.macfound.org/grants/ | -- | For a conference on women's health and economic development. Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| Andrew W. Mellon Foundation | 800,000.00 | 169 | Past Programs | https://mellon.org/grants/grants-database/grants/path/19600635/ | -- | Program name: Past Programs. | |
| Andrew W. Mellon Foundation | 750,000.00 | 173 | Past Programs | https://mellon.org/grants/grants-database/grants/path/19500666/ | -- | Program name: Past Programs. | |
| MacArthur Foundation | 350,000.00 | 210 | FIXME | https://www.macfound.org/grants/ | -- | To implement projects in India on credit, reproductive health services, and male involvement, as well as a project in the Philippines educating males who participate in high-risk sexual behavior (over two years). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| MacArthur Foundation | 150,000.00 | 249 | FIXME | https://www.macfound.org/grants/ | -- | For initiatives related to the Fund for Technology Transfer (over two years). Affected countries: United States; affected states: Washington; affected cities: Seattle. | |
| MacArthur Foundation | 1,500,000.00 | 118 | FIXME | https://www.macfound.org/grants/ | -- | Program-related investment to support the project that provides financial and technical assistance to organizations producing and/or introducing essential contraceptive and primary health technologies and services in developing countries. Affected countries: United States; affected states: Washington; affected cities: Seattle. |